Impact of MammaPrint and BluePrint on early breast cancer treatment decisions: WSG PRIMe study results

被引：0
|
作者：
Wuerstlein, R. [1 ]
Grischke, E. M. [2 ]
Gluz, O. [3 ]
Kates, R. [3 ]
Persoon, M. [4 ]
Thill, M. [5 ]
Hasmueller, S. [6 ]
Knauer, M. [7 ]
Pusch, R. [8 ]
Harbeck, N. [1 ,3 ]
机构：
[1] Univ Munich, Breast Ctr, Munich, Germany
[2] Univ Tubingen Hosp, Breast Canc Ctr, Tubingen, Germany
[3] WSG, Monchengladbach, Germany
[4] Agendia, Amsterdam, Netherlands
[5] Agaples Markus Hosp, Frankfurt, Germany
[6] Ebersberg Clin, Ebersberg, Germany
[7] Kantonsspital St Gallen, Breast Ctr, St Gallen, Switzerland
[8] Int Med IV Clin Wels Grieskirchen, Wels Grieskirchen, Austria
来源：
BREAST | 2017年 / 32卷
关键词：
D O I：
10.1016/S0960-9776(17)30341-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P255
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [31] Ki-67 versus MammaPrint/BluePrint for assessing luminal type breast cancer.
    Tian, Chen
    Fu, Lili
    Wei, Jiyu
    Yin, Pengfei
    Zhang, Henghui
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Improving personalized management of primary breast cancer: Mammaprint® risk stratification and blueprint® molecular subtyping
    Mikkilineni, L.
    Austin, L. K.
    Limentani, K.
    Jaslow, R. J.
    Avery, T. P.
    Palazzo, J.
    Cristofanilli, M.
    CANCER RESEARCH, 2016, 76
  • [33] Differential gene expression analysis and clinical utility of MammaPrint and BluePrint in male breast cancer patients
    Crozier, Jennifer
    Barone, Julie
    Banda, Kalyan
    Lesnikoski, Beth
    Maganini, Robert
    Diab, Sami
    Grady, Ian
    Lomis, Thomas
    Cox, Charles
    Truitt, Amy
    Nota, Benjamin
    Menicucci, Andrea
    Yoder, Erin
    Audeh, William
    CANCER RESEARCH, 2021, 81 (04)
  • [34] Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients
    Bichlien Nguyen
    Pino G. Cusumano
    Kenneth Deck
    Deborah Kerlin
    Agustin A. Garcia
    Julie L. Barone
    Edgardo Rivera
    Katharine Yao
    Femke A. de Snoo
    Jeroen van den Akker
    Lisette Stork-Sloots
    Daniele Generali
    Annals of Surgical Oncology, 2012, 19 : 3257 - 3263
  • [35] Staging early ovarian cancer: Impact on treatment decisions
    Freedman, Ralph S.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (05) : 856 - 858
  • [36] Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients (PATH) with early stage breast cancer
    Kunz, G.
    Dimpfl, T.
    Jakisch, C.
    Buttner, R.
    de Snoo, F.
    Krijgsman, O.
    van Lienen, E.
    Glas, A.
    Bender, R.
    BREAST, 2009, 18 : S34 - S34
  • [37] Comparison of MammaPrint® and TargetPrint® results with clinical parameters in German patients (path) with early stage breast cancer
    Gevensleben, H.
    Goering, U.
    Buettner, R.
    Heukamp, L. C.
    Kunz, G.
    Dimpfl, T.
    Jackisch, C.
    Ortmann, O.
    Albert, U-S
    Bender, R.
    de Snoo, F.
    Krijgsman, O.
    Glas, A. M.
    Ergoenenc, Y. H.
    Vogel, C.
    Dykgers, A.
    Langwieder, C.
    Rees, M.
    Anzeneder, T.
    ONKOLOGIE, 2010, 33 : 28 - 28
  • [38] Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early Stage Breast Cancer Patients
    Assi, Hazem I.
    Alameh, Ibrahim A.
    Khoury, Jessica
    Abdul Halim, Nour
    El Karak, Fadi
    Farhat, Fadi
    Berro, Juliett
    Sbaity, Eman
    Charafeddine, Maya
    Tfayli, Arafat
    Salem, Ziad
    El Saghir, Nagi
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [39] The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2− early breast cancer
    R Exner
    Z Bago-Horvath
    R Bartsch
    M Mittlboeck
    V P Retèl
    F Fitzal
    M Rudas
    C Singer
    G Pfeiler
    M Gnant
    R Jakesz
    P Dubsky
    British Journal of Cancer, 2014, 111 : 837 - 842
  • [40] The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer
    Exner, R.
    Bago-Horvath, Z.
    Bartsch, R.
    Mittlboeck, M.
    Retel, V. P.
    Fitzal, F.
    Rudas, M.
    Singer, C.
    Pfeiler, G.
    Gnant, M.
    Jakesz, R.
    Dubsky, P.
    BRITISH JOURNAL OF CANCER, 2014, 111 (05) : 837 - 842
12345